Research Instruments

Instruments

survey

NMOU Risk/History of Alcoholism and Substance Abuse
Symptom Assessment
Mood: Depression/Anxiety

Selected Publications

ReferenceCAGECAGE-AIDSOAPPESASFACT-GHADSPHQ-9GAD-7
Arthur J et al. Frequency, Predictors, and Outcomes of Urine Drug Testing Among Patients With Advanced Cancer on Chronic Opioid Therapy at an Outpatient Supportive Care Clinic. Cancer. 2016;122:3732-9. X X
Yennurajalingam S et al. Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy. BMJ Supportive & Palliative Care. 2020; 0:1-10. X X
Arthur J et al. Random vs Targeted Urine Drug Testing among patients undergoing long-term opioid treatment for cancer pain. JAMA Oncol. 2020; published online February 6, 2020. X X
Haider A, et al. Implications of the parenteral opioid shortage for prescription patterns and pain control among hospitalized patients with cancer referred to palliative care. JAMA Oncol. 2019;5(6):841-846. X X
Azhar A, et al. Frequency of concomitant use of opioids and psychoactive medications among cancer patients referred to outpatient palliative care. JPSM. 2019;57(6):e7-e10. X X
Yennurajalingam S, et al. Patterns of opioid prescription, use, and costs among patients with advanced cancer and inpatient palliative care between 2008 and 2014. J Oncol Pract. 2019;15(1):e74-e83. X X
Dev R, et al. Association between tobacco use, pain expression, and coping strategies among patients with advanced cancer. Cancer. 2019;125(1):153-160. X X X
Azhar A, et al. Response to oral immediate-release opioids for breakthrough pain in patients with advanced cancer with adequately controlled background pain. Oncologist. 2019;24(1):125-131. X X
Yennurajalingam S, et al. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center. Cancer. 2018;124(19):3942-3949. X X X
Arthur J, et al. Outcomes of a specialized interdisciplinary approach for patients with cancer with aberrant opioid-related behavior. Oncologist. 2018;23(2):263-270. X X